Psychopharmacology and memory

Journal of Medical Ethics

Volumn 32, Issue 2, 2006, Pages 74-78

  Glannon, Walter ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DONEPEZIL; MEMANTINE; METHYLPHENIDATE; PLACEBO; PROPRANOLOL; PSYCHOTROPIC AGENT;

ALZHEIMER DISEASE; AMYGDALOID NUCLEUS; ANXIETY; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; EMOTIONAL DISORDER; FEAR; HEART ARRHYTHMIA; HIPPOCAMPUS; HUMAN; LONG TERM MEMORY; MEDICAL ETHICS; MEMORY; MENTAL DISEASE; MOOD DISORDER; POSTTRAUMATIC STRESS DISORDER; PREFRONTAL CORTEX; PSYCHOPHARMACOLOGY; WORKING MEMORY;

ADRENERGIC BETA-ANTAGONISTS; AMYGDALA; BRAIN; COGNITION; CREB-BINDING PROTEIN; EMOTIONS; HUMANS; MEMORY; NEURONS; PROPRANOLOL; PSYCHOPHARMACOLOGY; PSYCHOTROPIC DRUGS; STRESS DISORDERS, POST-TRAUMATIC;

EID: 32544440772     PISSN: 03066800     EISSN: None     Source Type: Journal    
DOI: 10.1136/jme.2005.012575     Document Type: Article

References (22)

1. LeDoux J. The emotional brain. New York: Simon & Schuster, 1996.
2. LeDoux J. The synaptic self. New York: Norton, 2002, ch 3.
3. Strange B, Hurlemann R, Dolan R. An emotion induced retrograde amnesia in humans is amygdala and beta-adrenergic dependent. PNAS 2003;100:13626-31.
4. Pittman R, Sanders K, Zusman R, et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry 2002;51:189-92.
5. Miller G. Learning to forget. Science 2004;302:34-6.
6. Hoge C, Castro C, Messer S, et al. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. New Engl J Med 2004;351:13-22.
7. US President's Council on Bioethics, seventh meeting, October 17, 2002, session 3: Remembering and forgetting: physiological and pharmacological aspects. www.bioethics.gov/transcripts/oct02/session3.html (accessed 22 Jul 2005).
8. Kass L. Beyond therapy: biotechnology and the pursuit of happiness. New York: Harper Collins, 2003.
9. Schacter D. Searching for memory. New York: Basic Books, 1996, ch 5.
10. Tully T, Bourtchouladze R, Gossweiler S, et al. Targeting the CREB pathway for memory enhancers. Nat Rev Drug Discov 2003;2:267-77.
11. Scott R, Bourtchouladze R, Gossweiler S, et al. CREB and the discovery of cognitive enhancers. Journal of Molecular Neuroscience 2002;19:171-7.
12. Lynch G. Memory enhancement: the search for mechanism-based drugs. Nature Neurosci 2002;5:1035-8.
13. Tulving E. Where in the brain is the awareness of one's post? In: Schacter D, Scarry E, eds. Memory, brain, and belief. Cambridge, MA: Harvard University Press, 2000:208-28.
14. Tulving E. Episodic memory: from mind to brain. Annu Rev Psychol 2002;53:27-51.
15. Squire L. Declarative and non-declarative memory: multiple brain systems support learning and memory. In: Schacter D, Tulving E, eds. Memory systems. Cambridge, MA: MIT Press, 1994:203-32.
16. Farah M. Emerging ethical issues in neuroscience. Nat Neurosci 2002;2:1123-9 at 1125.
17. Farah M, Illes J, Cook-Degan R, et al. Neurocognitive enhancement: what can we do? What should we do? Nat Rev Neurosci 2004;5:421-5.
18. Hyman S, Fenton W. What are the right targets for psychopharmacology? Science 2003;299:350-1.
19. Jakobson Ramin C. In search of lost time. New York Times Magazine 2004 Dec 5:11-17 at 15.
20. Blair RJR. Neurological basis of psychopathy. Br J Psychiatry 2003;182:5-7.
21. Hare RD. The Hare psychopathy checklist. Toronto: Multi-Health Systems, 1991.
22. Cleckley H. The mask of sanity. St Louis: Mosby, 1967.